Biologic Markers in Reproductive Toxicology

Biologic Markers in Reproductive Toxicology

  • Publisher: National Academies Press
  • ISBN: 9780309039796
  • eISBN Pdf: 9780309568142
  • Place of publication:  United States
  • Year of digital publication: 1989
  • Month: January
  • Pages: 420
  • Language: English

Does exposure to environmental toxicants inhibit our ability to have healthy children who develop normally? Biologic markers—indicators that can tell us when environmental factors have caused a change at the cellular or biochemical level that might affect reproductive ability—are a promising tool for research aimed at answering that important question. Biologic Markers in Reproductive Toxicology examines the potential of these markers in environmental health studies; clarifies definitions, underlying concepts, and possible applications; and shows the benefits to be gained from their use in reproductive and neurodevelopmental research.

  • Biologic Markers in Reproductive Toxicology
  • Copyright
  • Preface
  • Contents
  • Executive Summary
    • ORGANIZATION OF THIS REPORT
    • CONCEPTS AND DEFINITIONS
      • Markers of Exposure
      • Markers of Effect
      • Markers of Susceptibility
    • EXTRAPOLATION FROM ANIMALS TO HUMANS
    • QUALITY AND QUANTITY OF DATA
    • BIOLOGIC MARKERS ASSOCIATED WITH REPRODUCTIVE AND NEURODEVELOPMENTAL TOXICOLOGY
    • BIOLOGIC MARKERS ASSOCIATED WITH MALE REPRODUCTION
      • Markers of Physiologic Damage
      • Markers of Genetic Damage and Heritable Mutations
    • BIOLOGIC MARKERS ASSOCIATED WITH FEMALE REPRODUCTION
      • Germ Cell Damage
      • Development and Aging
      • Cyclic Ovarian Function
      • Fertilization, Implantation, and Early Loss
    • BIOLOGIC MARKERS ASSOCIATED WITH PREGNANCY
    • BIOLOGIC MARKERS ASSOCIATED WITH NEURODEVELOPMENT
    • GENERAL RECOMMENDATIONS AND CONCLUSIONS
  • 1 Report of the Oversight Committee
    • CONCEPTS AND DEFINITIONS
      • Biologic Markers of Exposure
      • Biologic Markers of Effect
      • Biologic Markers of Susceptibility
    • PRINCIPLES OF SELECTION OF MARKERS
      • Biologic Considerations
      • Practical Limitations
      • Batteries of Biologic Markers
      • Ethical Issues
    • VALIDATION OF BIOLOGIC MARKERS
      • Sensitivity and Specificity
      • Uses
      • Animal Models
      • Quality Assurance
      • Sensitivity of Measurements
      • Markers of Specific Exposures
    • ECOLOGIC MARKERS
    • USE OF BIOLOGIC MARKERS IN RISK ASSESSMENT
    • EXTRAPOLATION FROM ANIMALS TO HUMANS
    • QUALITY AND QUANTITY OF DATA
    • IMPLEMENTATION OF BIOLOGIC MARKERS IN POPULATION STUDIES
    • LONG-TERM TISSUE AND CELL STORAGE FOR RETROSPECTIVE ANALYSIS
    • USE OF BIOLOGIC MARKERS IN REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY
      • Studies of Male Reproductive Toxicants
      • Studies of Female Reproductive Toxicants
      • Studies of Pregnancy Toxicants
      • Studies of Neurodevelopmental Toxicants
    • SUMMARY
  • I Biologic Markers in Male Reproductive and Gametic Genetic Toxicology
    • 2 Introduction
      • BIOLOGIC MARKERS OF MALE PHYSIOLOGIC DAMAGE
      • BIOLOGIC MARKERS OF GENETIC DAMAGE AND HERITABLE MUTATIONS IN HUMAN GERM CELLS
      • IMPORTANCE OF ANIMAL STUDIES IN MARKER DEVELOPMENT
      • ORGANIZATION OF MALE REPRODUCTION SECTION
    • 3 Clinical Evaluation of Male Infertility
      • MEDICAL HISTORY
      • PHYSICAL EXAMINATION
      • SEMEN CHARACTERISTICS
    • 4 Biologic Markers of Testicular Function
      • PHYSICAL AND CHEMICAL MARKERS OF TESTICULAR FUNCTION
        • Markers in Use
        • Markers Requiring Research and Development
      • LEYDIG CELLS
        • Markers in Use
        • Markers Requiring Research and Development
      • SEMINIFEROUS TUBULES
        • Sertoli Cells
          • Markers in Use
          • Markers Requiring Research and Development
        • Germ Cells
          • Markers in Use
          • Markers Requiring Research and Development
    • 5 Biologic Markers of Epididymal Structure and Function
      • MARKERS OF EPIDIDYMAL TISSUE
      • CHANGES IN MATURING SPERMATOZOA
        • Structural Changes
        • Biochemical Changes
        • Functional Changes
          • Content of Epididymal Spermatozoa
          • Transport of Spermatozoa
          • Acquisition of Fertilizing Ability
          • Storage of Spermatozoa
      • EPIDIDYMAL LUMINAL FLUID
      • EPIDIDYMAL EPITHELIAL FUNCTION
        • Histology
          • Presence and Relative Distribution of Various Cell Types
          • Blood-Epididymis Barrier
          • Spermiophagy
        • Biochemical Markers
          • Hormone Receptors and Regulation of Epididymal Function
          • Steroid Biosynthesis and Metabolism
          • Intermediary Metabolism
      • EPIDIDYMALLY MEDIATED TOXIC DRUG EFFECTS
    • 6 Biologic Markers of Accessory Sex Organ Structure and Function
      • PHYSICAL MARKERS
      • STRUCTURAL MARKERS
      • FUNCTIONAL MARKERS
    • 7 Biologic Markers of Human Male Reproductive Health and Physiologic Damage
      • NEEDS FOR BIOLOGIC MARKERS OF HUMAN MALE REPRODUCTIVE HEALTH
      • EPIDEMIOLOGIC STUDIES OF HUMAN SPERM PRODUCTION AND FERTILITY
        • Epidemiologic Surveys of Fertility Status
        • Markers of Early Pregnancy
        • Cohort Studies with Semen and Blood Samples
      • HUMAN SPERMATOGENESIS AND DEVELOPMENT OF SEMEN-BASED MARKERS OF MALE REPRODUCTIVE HEALTH
      • PHYSICAL CHARACTERISTICS OF THE HUMAN EJACULATE
      • PRESENCE OF NONSPERM CELLS IN SEMEN
      • SPERM NUMBER
        • As Marker of Sperm Production
        • As Marker of Fertility Status
        • As Indicator of Exposure to Toxic Agents
        • Other Factors That Affect Sperm Number
      • SPERM STRUCTURE
        • As Marker of the Quality of Sperm Production
        • As Marker of Fertility Status
        • As Indicator of Exposure to Toxic Agents
        • Other Factors That Affect Sperm Structure
      • SPERM MOTILITY
        • As Marker of Sperm Function
        • As Marker of Fertility Status
        • As Indicator of Exposure to Toxic Agents
        • Other Factors That Affect Sperm Motility
      • SPERM VIABILITY
      • SPERM FUNCTION
        • Cervical-Mucus Penetration
        • Sperm-Oocyte Interaction
      • OTHER SPERM MEASUREMENTS
        • Sperm Agglutination
        • Nuclear Chromatin
        • Double F Bodies
      • CHEMICAL COMPOSITION OF SEMINAL FLUID
      • PROMISING RESEARCH CONCEPTS
        • Automated Sperm Measurements
          • Machine-Based Sperm-Motility Measurements
          • Quantitative Sperm Structure
          • General Considerations Regarding Automated Methods
        • Markers of Sperm Function
        • Immunologic Reagents for Studies of Semen and Spermatogenesis
          • Sperm Surface Domains
          • Components in the Sperm
          • Use of Antibodies for Studying Gene Expression
          • Antibodies for Characterizing Semen
      • SEMEN MARKERS OF SERTOLI CELL AND LEYDIG CELL FUNCTION
      • RECOMBINANT-DNA METHODS FOR STUDY OF HUMAN SPERMATOGENESIS AND SEMEN
    • 8 Assessing Transmitted Mutations in Mice
      • ASSESSING MARKERS IN LABORATORY ANIMALS
      • MARKERS OF EXPOSURE
        • Cytotoxicity
        • Cytogenetic Effects
        • Biochemical Responses
        • Molecular Binding
        • Cellular Morphologic Responses
      • TESTS IN MICE TO DETERMINE TRANSMITTED GENETIC EFFECTS
        • Specific-Locus Test with Visible Markers
        • Specific-Locus Test with Biochemical Markers
        • Specific-Locus Test with Immunologic Markers (H Test)
        • Recessive Lethal Test
        • Dominant Lethal Test
        • Heritable-Translocation Test
        • Inversions
        • Sex-Chromosome Loss
        • Nondisjunction Test
        • Cytogenetic Analysis of Zygotes
        • Tests for Dominant Mutations
      • NEEDED RESEARCH ON GENETIC DAMAGE IN LABORATORY ANIMALS
        • Relationship Between Molecular Target Sites and Production of Various Types of Mutations
        • Molecular Nature and Expression of Mutations
        • Mutagen-Caused Induction of Integration of Endogenous Transposable Elements in New Sites
        • Mouse Mutants as Models of Human Genetic Diseases
        • Nondisjunction
        • DNA Methods
    • 9 Markers for Measuring Germinal Genetic Toxicity and Heritable Mutations in People
      • CURRENT METHODS FOR MEASURING HUMAN HERITABLE MUTATIONS
        • Sentinel Phenotypes
        • Chromosomal Abnormalities
        • Prevalence of Chromosomal Abnormalities at Birth
        • Mutant Proteins
      • RESULTS OF EPIDEMIOLOGIC STUDIES OF HUMAN HERITABLE MUTATIONS IN EXPOSED POPULATIONS
        • Atomic Bomb Survivors
        • Survivors of Cancer Chemotherapy
        • Other Exposure Groups
      • HUMAN SOMATIC MUTATION METHODS
        • Detection of Somatic Mutations in White Blood Cells
        • Detection of Somatic Mutations in Red Blood Cells
      • NEW MOLECULAR APPROACHES FOR DETECTING HUMAN HERITABLE MUTATIONS
        • DNA Sequencing
        • Restriction-Fragment-Length Polymorphism (RFLP)
        • Ribonuclease Cleavage
        • Subtractive Hybridization
        • Pulse-Field Gel Electrophoresis
        • One-Dimensional Denaturing Gel Electrophoresis
        • Two-Dimensional Denaturing Gradient Gel Electrophoresis
      • TESTICULAR MARKERS OF HUMAN GERMINAL CYTOGENETIC DAMAGE
      • SEMEN MARKERS OF HUMAN GERMINAL MUTATIONS AND GENETIC TOXICITY
        • Cytogenetics of Human Sperm
        • Sperm-DNA Alkaline Elution
        • Specific-Locus Mutations in Sperm
        • DNA Adduction in Sperm
        • Aneuploidy Detection in Sperm
        • Cytogenetic Analysis of Meiotic Cells in Semen
        • Micronuclei in Seminal Spermatids
      • SUMMARY
    • 10 Conclusions and Recommendations
      • IDENTIFICATION OF MARKERS OF ABNORMAL PHYSIOLOGIC FUNCTION
        • Testes
        • Epididymis
        • Accessory Sex Organs
      • SEMEN MARKERS OF ABNORMAL PHYSIOLOGIC FUNCTION
      • NEED FOR IMPROVED MEASURES OF FERTILITY STATUS AND EXPOSURE
      • IDENTIFICATION OF MARKERS OF GERMINAL GENETIC TOXICITY AND HERITABLE MUTATIONS
      • CRITERIA FOR DEVELOPMENT AND VALIDATION OF MARKERS OF MALE REPRODUCTION
      • STRATEGY FOR TESTING EFFECT OF TOXIC CHEMICALS ON MARKERS OF MALE REPRODUCTION
  • II Biologic Markers in Female Reproductive Toxicology
    • 11 Introduction
      • OOGENESIS
      • DEVELOPMENT OF THE FEMALE REPRODUCTIVE TRACT
      • MATURATION
        • Hormonal Changes
        • Menarche
        • Adrenarche
        • Thelarche
      • CYCLIC OVARIAN FUNCTION
      • FERTILIZATION
      • REPRODUCTIVE SENESCENCE
    • 12 Biologic Markers of Genetic Damage in Females
      • MARKERS OF EXPOSURE
      • MARKERS OF OOCYTE TOXICITY
      • MARKERS OF GENOTOXIC DAMAGE OR REPAIR
        • DNA Adducts
        • Unscheduled DNA Synthesis
        • Sister-Chromatid Exchange
      • MARKERS OF MUTATIONAL EVENTS
        • Laboratory Animals
        • Human Oocytes
        • Human Somatic Cells
          • Chromosomal Aberrations
          • Micronuclei
          • Specific-Locus Mutations
    • 13 Biologic Markers of Reproductive Development and Aging
      • MARKERS OF MATURATION
        • Adrenarche
        • Ovary and Uterus
        • Menarche
        • Thelarche and Pubic Hair
      • MENSTRUATION
        • LOSS OF FERTILITY AND FECUNDITY
      • PRECOCIOUS MENOPAUSE
      • OVARIAN OOCYTE DEPLETION
      • HORMONES
        • Gonadotropins
        • Steroids
      • NERVOUS SYSTEM
        • Behavior
        • Cell Populations
      • OBSERVATIONS ON THE USE OF THESE MARKERS
        • Need for Multiple Biologic Markers
        • Differential Susceptibility of Individuals and Populations
        • Analysis of Menstrual Cycle Lengths
        • Long-Term Neurologic Consequences of Toxicant Exposure
    • 14 Biologic Markers of Nonconceptive Menstrual Cycles
      • SPECIFIC MARKERS
        • Cyclicity
        • Character of Menstrual Flow
        • Detection of Corpus Luteum
          • Progesterone in the Peripheral Serum
          • Basal Body-Temperature Shift
          • Cervical Mucus Changes
          • Vaginal Cytology
          • Endometrial Histology
          • Secretion of Progesterone-Stimulated Endometrial Proteins into Uterine Lumen
        • Reproductive Endocrinology In Vivo
        • In Vitro Markers
      • BIOLOGIC RATIONALE
    • 15 Developing Assays of Biologic Markers for Epidemiologic Studies: Experience with a Marker of Pregnancy and Early Loss
      • ASSAYS OF HCG
      • FIELD STUDIES OF EARLY FETAL LOSS: TESTING THE UTILITY OF THE HCG ASSAY
      • FUTURE ASSAY DEVELOPMENTS
        • Improved Methods for hCG Detection
        • New Monoclonal Antibodies for hCG Detection
        • Nonradioactive Methods for hCG Detection
        • Requirement to Measure Other Biologic Markers
        • OTHER CLINICAL OPPORTUNITIES
    • 16 Conclusions and Recommendations
      • SPECIAL RESEARCH OPPORTUNITIES
      • SPECIFIC RESEARCH RECOMMENDATIONS
        • Germ Cell Damage
        • Sexual Differentiation
        • Puberty
        • Ovulation
        • Clinically Inapparent Loss
        • Ovarian Senescence
      • NATIONAL DATA BASE
        • EXPERIMENTAL STUDIES
  • III Biologic Markers of Toxicity During Pregnancy
    • 17 Introduction
      • THE EVENTS OF PREGNANCY
      • MATERNAL PHYSIOLOGY
      • EMBRYONIC/FETAL CHANGES
      • PLACENTAL INVOLVEMENT
    • 18 Molecular Biology: Developing DNA Markers of Genotoxic Effects
      • DETECTING HERITABLE GENETIC DAMAGE
      • MARKERS OF EXPOSURE
    • 19 Reproductive Immunology: Biologic Markers of Compromised Pregnancies
      • MATERNAL IMMUNOLOGIC RECOGNITION AND REACTION DURING NORMAL PREGNANCY
      • TESTS TO DETERMINE MARKERS OF MECHANISMS OF RECURRENT PREGNANCY LOSS
        • Mixed-Lymphocyte-Culture Reactions
        • Lymphocytotoxic Antibodies and Histocompatibility Typing
        • Autoimmunity Tests
      • PROMISING MARKERS OF MATERNAL-FETAL INTERACTIONS
        • Trophoblast Antigens and Classes of Couples with Recurrent Spontaneous Abortions
        • Major Basic Protein
        • Early Pregnancy Factor
      • PROMISING TECHNIQUES THAT MIGHT YIELD BIOLOGIC MARKERS
        • Fluorescence-Activated Cell Sorting
        • Immunotherapy to Prevent Spontaneous Abortion
        • Immunopharmacology
    • 20 Cell Biology: Identifying Biologic Markers Expressed During Early Pregnancy
      • IMPLANTATION
      • ASSESSING ENDOMETRIAL SIGNALS
        • Uterine Secretions
        • Uterine Epithelial Cells
        • Uterine Stromal Cells
        • Investigations of Cervix and Vagina
      • TROPHOBLAST BIOLOGIC MARKERS
        • Trophectoderm
        • Steroidogenesis
        • Trophoblast Giant Cells and Placental Hormones
        • Trophoblast Giant Cell Cytoskeleton
        • Ectoplacental Cone Cells
        • Regulation of Trophoblast Hormone Synthesis
      • EXTRAPOLATION TO HUMAN TROPHOBLASTS
        • Human Chorionic Gonadotropin
        • Placental Lactogens
        • Pregnancy-Associated Factors
    • 21 Physiologic Assessment of Fetal Compromise
      • ULTRASONOGRAPHY
      • AMNIOCENTESIS
      • CHORIONIC VILLUS SAMPLING
      • FETOSCOPY
      • FETAL BLOOD AND TISSUE SAMPLING
      • MEASURING FETAL BODY AND BREATHING MOVEMENTS
      • ELECTRONIC FETAL HEART-RATE MONITORING
      • BIOPHYSICAL PROFILE
      • MAGNETIC RESONANCE IMAGING
    • 22 Biologic Markers of Exposure During Pregnancy: Pharmacokinetic Assessments
      • ASSESSMENTS FOR PHARMACOKINETIC ANALYSES
      • CURRENT AND PROMISING MARKERS
    • 23 Conclusions and Recommendations
      • RESEARCH STRATEGIES
      • ACCOMPLISHING THE RESEARCH GOAL
      • BRINGING THE ASSAY OUT OF THE LABORATORY AND INTO THE PUBLIC HEALTH DOMAIN
      • ASSESSMENTS OF THE STATUS OF SPECIFIC MARKERS RELATED TO PREGNANCY
        • Markers of Effect Before and Around Implantation
        • Organogenesis
        • The Fetal and Neonatal Period
      • MARKERS OF EXPOSURE
  • IV Biologic Markers in Neurodevelopmental Toxicology
    • 24 Introduction
      • BIOLOGIC MARKERS OF EXPOSURE: PHARMACOKINETIC CONSIDERATIONS
      • BIOLOGIC MARKERS OF EFFECT: PHARMACODYNAMIC CONSIDERATIONS
        • Markers in the Mother
        • Placental Markers
        • Markers in the Newborn
        • Markers in Children
    • 25 Developmental Neurobiology of the Central Nervous System
      • BASIC MORPHOGENESIS
      • BASIC CYTOGENESIS
        • Development of Major Subdivisions
        • Specific Development of Neuronal Type
      • NEUROCHEMISTRY OF NEURONAL COMMUNICATION
    • 26 Morphologic, Neurochemical, and Behavioral Responses to Toxic Agents
      • EFFECTS OF TIME OF EXPOSURE AND DOSE: IRRADIATION AS A PARADIGM
      • MICRONEURONAL RADIATION
        • Cerebellum
        • Hippocampus
      • APPLICATION TO OTHER TOXIC SUBSTANCES
      • RELATIONSHIP BETWEEN MINOR PHYSICAL ANOMALIES AND BEHAVIORAL EFFECTS
      • NEUROCHEMICAL EFFECTS
      • BEHAVIORAL EFFECTS
    • 27 Methodologic Issues of Extrapolation from Animal Studies to Human Toxicant Exposure
      • INVESTIGATION OF UNDERLYING MECHANISMS
      • STUDY OF COMPARABLE FUNCTIONAL END
      • DIRECT COMPARISONS BETWEEN ANIMALS AND HUMANS
      • DATA INTERPRETATION
    • 28 Lead as a Paradigm for the Study of Neurodevelopmental Toxicity
      • MARKERS OF EXPOSURE TO LEAD
        • Surrogate Markers
        • Blood Lead
        • Hair Lead
        • Erythrocyte Protoporphyrin
        • Chelatable Lead
        • Bone Lead
        • Tooth Lead
        • X-ray Fluorescence of Bone
      • MARKERS OF EFFECT
      • MARKERS OF SUSCEPTIBILITY
      • METHODOLOGIC CONSIDERATIONS IN THE ESTABLISHMENT AND EVALUATION OF MARKERS OF DEVELOPMENT
        • Differentiating Markers of Exposure and Effect
      • ADVERSE HEALTH EFFECTS
        • Causal Inferences in Toxicant Exposure
    • 29 Conclusions and Recommendations
      • MODELS OF NEURODEVELOPMENT
      • NEUROENDOCRINE AND NEUROIMMUNOLOGIC MARKERS
        • Nervous System-Endocrine Interactions
        • Nervous System-Immune System Interactions
      • NEUROCHEMICAL MARKERS
        • Recent Advances in Neurochemical Methods
        • Surrogate Cell Systems
  • Appendix
  • Appendix Assessing the Validity of Biologic Markers: Alpha-Fetoprotein
    • ASSESSING THE VALIDITY OF BIOLOGIC MARKERS
      • VALIDITY OF MATERNAL SERUM AFP MEASUREMENT AS A BIOLOGIC MARKER OF NTDs
  • References
  • Biographies
  • Index

SUBSCRIBE TO OUR NEWSLETTER

By subscribing, you accept our Privacy Policy